HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED
Clinical trials for HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED trials appear
Sign up with your email to follow new studies for HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists track rare nerve and heart disease in unexpected location
Knowledge-focused Recruiting nowThis study looks at 57 people aged 20 to 70 who carry a specific genetic change (Val50Met) linked to hereditary ATTR amyloidosis, a rare disease that can damage nerves and the heart. Researchers want to describe the different ways the disease shows up—mainly heart problems, mainl…
Matched conditions: HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED
Sponsor: Hospital 9 de Julio de Las Breñas • Aim: Knowledge-focused
Last updated May 17, 2026 13:58 UTC
-
New study tracks nerve damage marker in rare genetic disease
Knowledge-focused Recruiting nowThis study looks at a protein called NfL in the blood of people who carry a TTR gene variant, both those without symptoms and those with hATTR amyloidosis affecting nerves. The goal is to see if NfL levels can help detect when the disease starts, how it progresses, and how well t…
Matched conditions: HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated May 08, 2026 12:05 UTC